Advertisement

Clinical Rheumatology

, Volume 16, Issue 6, pp 617–622 | Cite as

Case report and review of the literature fatal pulmonary complication in ankylosing spondylitis

  • E. S. Strobel
  • E. Fritschka
Case Report

Summary

A 44-year-old non-smoking patient with longstanding ankylosing spondylitis presented in marked respiratory distress with tachypnea, fever, cough, greenish sputum, night sweats, dyspnea and weight loss. Computed tomography showed traction bronchiectases and cavities associated iwth scarring. The findings were most pronounced in the upper lobes which contained multiple cavities up to 8 cm in diameter harboring fungus balls. The superior segment of the left lower lobe showed two additional cavities. Tuberculosis and atypical mycobacteria were ruled out. Antibiotic therapy resulted in transient improvement. Five months after this acute exacerbation the patient expired from massive haemoptysis. Pulmonary fibrosis is a rare manifestation of ankylosing spondylitis, may be complicated by infection and haemorrhage and determine the dismal prognosis of these patients.

Key words

Ankylosing Spondylitis Pulmonary Fibrosis Aspergilloma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dougados, M. Diagnostic features of ankylosing spondylitis. Br J Rheumatol 1995; 34: 301–3.Google Scholar
  2. 2.
    Stamato T, Laxer RM, de Freitas C, Gow R, Silverman ED, Luy L, Smallhorn JF. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. Am J Cardiol 1995; 75: 744–6.Google Scholar
  3. 3.
    Sant SM, O'Connell D. Cauda equina syndrome in ankylosing spondylitis: a case report and review of the literature. Clin Rheumatol 1995; 14: 224–6.Google Scholar
  4. 4.
    Haslock I. Ankylosing spondylitis. Baillière's Clin Rheumatol 1993; 7: 99–115.Google Scholar
  5. 5.
    Hermanns MJ, Schulte K, Hartl WP. Narbig-wabiger Lungenober-lappenumbau bei ankylosierender Spondylitis (Morbus Strümpell-Marie-Bechterew). Prax Klin Pneumol 1985; 39: 902–3.Google Scholar
  6. 6.
    Campbell AH, MacDonald CB. Upper lobe fibrosis associated with ankylosing spondylitis. Brit J Dis Chest 1965; 59: 90–101.Google Scholar
  7. 7.
    Jessamine AG. Upper lung lobe fibrosis in ankylosing spondylitis. Canad Med Ass J 1968; 98: 25–9.Google Scholar
  8. 8.
    Riemann I, Riemann F, Schilling F. Lungenbeteiligung bei der Spondylitis ankylopoetica. Prax Pneumol 1974; 28: 148–57.Google Scholar
  9. 9.
    Marowski B, Voigt R, Minck C. Zystische Oberlappenfibrose bei Spondylitis ankylopoetica. Dtsch med Wschr 1982; 107: 220–2.Google Scholar
  10. 10.
    Ferdoutsis M, Bouros D, Meletis G, Patsourakis G, Siafakas NM. Diffuse interstitial lung disease as an early manifestation of ankylosing spondylitis. Respiration 1995; 62: 286–9.Google Scholar
  11. 11.
    Davies D. Ankylosing spondylitis and lung fibrosis. Quart J Med 1972; 41: 395–417.Google Scholar
  12. 12.
    Rosenow III EC, Strimlan CV, Muhm JR, Ferguson RH. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Pro 1977; 52: 641–9.Google Scholar
  13. 13.
    Hendrix WC, Arruda LK, Platts-Mills TAE, Haworth CS, Jabour R, Ward GW. Jr. Aspergillus epidural abscess and cord compression in a patient with aspergilloma and empyema. Survival and response to high dose systemic amphotericin therapy. Am Rev Respir Dis 1992; 145: 1483–6.Google Scholar
  14. 14.
    Cohen AM, Coates DP. Fractured hip in a patient with ankylosing spondylitis and pulmonary fibrosis. Br J Hosp Med 1995; 53: 119.Google Scholar
  15. 15.
    Blavia R, Toda MR, Vidal F, Benet A, Razquin S, Richart C. Pulmonary diffuse amyloidosis and ankylosing spondylitis. A rare association. Chest 1992; 102: 1608–10.Google Scholar
  16. 16.
    Turner JF, Enzenauer RJ. Bronchiolitis obliterans and organizing pneumonia associated with ankylosing spondylitis. Arthritis Rheum 1994; 37: 1557–9.Google Scholar
  17. 17.
    Kentala E, Repo UK, Lehtipuu AL, Vuornos T. HLA-antigens and pulmonary upper lobe fibrocystic changes with and without ankylosing spondylitis. Scand J resp Dis 1978; 59: 8–12.Google Scholar
  18. 18.
    Hillerdal G. Ankylosing spondylitis lung disease - an underdiagnosed entity? Eur J Respir Dis 1983; 64: 437–41.Google Scholar
  19. 19.
    Levy H, Hurwitz MD, Strimling M, Zwi S. Ankylosing spondylitis lung disease and mycobacterium scrofulaceum. Br J Dis Chest 1988; 82: 84–7.Google Scholar
  20. 20.
    Schönfeld N, Matthiessen W, Grassor A. Komplikationen der pulmonalen Beteiligung beim M.Bechterew. Akt Radiol 1991; 1: 249–52.Google Scholar
  21. 21.
    Nef W, Huonder M, Kuhn M, Reinhart WH. Fibrozystische Veränderungen eines Lungenoberlappens - eine seltene Spätkomplikation der ankylosierenden Spondylitis. Schweiz Rundschau Med 1992; 81: 736–9.Google Scholar
  22. 22.
    Knöll P, Wiesner B, Jäger J. Zystisch-fibrotische Lungenveränderungen mit Aspergillom bei der Spondylitis ankylosans. Prax Klin Pneumol 1988, 42, 55–58.Google Scholar
  23. 23.
    Boushea DK, Sundstrom WR. The pleuropulmonary manifestations of ankylosing spondylitis. Semin Arthritis Rheum 1989; 18: 277–81.Google Scholar

Copyright information

© Clinical Rheumatology 1997

Authors and Affiliations

  • E. S. Strobel
    • 1
  • E. Fritschka
    • 2
  1. 1.Department of MedicineKlinikum der Albert-Ludwigs-Universität FreiburgFreiburgGermany
  2. 2.LVA-Sinntalklinik Bad BrückenauGermany

Personalised recommendations